Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer
2013 (English)In: Journal of Biochemistry (Tokyo), ISSN 0021-924X, E-ISSN 1756-2651, Vol. 154, no 5, 395-408 p.Article in journal (Refereed) Published
Clinical and experimental data indicate that hyaluronan accumulates in breast cancer compared with normal breast epithelium, which correlates to poor prognosis. In this review, we discuss the expression of genes encoding enzymes that synthesize or degrade hyaluronan, i.e. hyaluronan synthases and hyaluronidases or bind hyaluronan, i.e. CD44 and receptor for hyaluronan-mediated motility (RHAMM, also designated as HMMR or CD168), in relation to breast cancer progression. Hyaluronan and hyaluronan receptors have multi-faceted roles in signalling events in breast cancer. A better understanding of the molecular mechanisms underlying these signalling pathways is highly warranted and may lead to improvement of cancer treatment.
Place, publisher, year, edition, pages
2013. Vol. 154, no 5, 395-408 p.
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:uu:diva-211067DOI: 10.1093/jb/mvt085ISI: 000326652500001PubMedID: 24092768OAI: oai:DiVA.org:uu-211067DiVA: diva2:665221